RA CAPITAL MANAGEMENT, L.P. Diversified Active

CIK: 0001346824 · Show all filings

Period: Q4 2013 (← Previous) (Next →)

Filing Date: Feb 14, 2014

Total Value ($000): $858,468 (100.0% shares, 0.0% debt)

Holdings (31)

ACAD ACADIA PHARMACEUTICALS INC 15.3%
Value ($000) $131,198 Shares 5,250,000 Est. Cost $13.77 Unrealized +71.3%
ACHILLION PHARMACEUTICALS IN 9.0%
Value ($000) $77,552 Shares 23,366,007 Est. Cost $4.78 Unrealized
SGMO SANGAMO BIOSCIENCES INC 8.5%
Value ($000) $72,607 Shares 5,227,272 Est. Cost $9.24 Unrealized +24.6%
THERAPEUTICSMD INC 7.1%
Value ($000) $60,749 Shares 11,660,108 Est. Cost $3.00 Unrealized
NOVAVAX INC 6.4%
Value ($000) $55,357 Shares 10,811,888 Est. Cost $2.24 Unrealized
OPHTHOTECH CORP 6.0%
Value ($000) $51,775 Shares 1,600,455 Est. Cost $32.35 Unrealized
PRTA PROTHENA CORP PLC 5.1%
Value ($000) $43,524 Shares 1,641,167 Est. Cost $15.16 Unrealized +65.5%
SGMO SANGAMO BIOSCIENCES INC 4.9%
Value ($000) $41,670 Shares 3,000,000 Est. Cost $9.24 Unrealized +24.6%
DYNAVAX TECHNOLOGIES CORP 4.1%
Value ($000) $35,053 Shares 17,883,954 Est. Cost $1.67 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 3.8%
Value ($000) $33,041 Shares 4,347,456 Est. Cost $5.07 Unrealized +24.8%
ACAD ACADIA PHARMACEUTICALS INC 3.4%
Value ($000) $29,236 Shares 1,169,898 Est. Cost $13.77 Unrealized +71.3%
XNCR XENCOR INC 2.9%
Value ($000) $24,907 Shares 2,725,000 Est. Cost $8.58 Unrealized 0.0%
SUNESIS PHARMACEUTICALS INC 2.7%
Value ($000) $23,080 Shares 4,869,261 Est. Cost $5.18 Unrealized
ARROWHEAD RESH CORP 2.6%
Value ($000) $22,234 Shares 2,049,220 Est. Cost $7.05 Unrealized
DERMA SCIENCES INC 2.5%
Value ($000) $21,585 Shares 1,994,876 Est. Cost $13.35 Unrealized
TESARO INC 2.3%
Value ($000) $19,768 Shares 700,000 Est. Cost $28.24 Unrealized
PTCT PTC THERAPEUTICS INC 1.5%
Value ($000) $12,769 Shares 752,438 Est. Cost $17.50 Unrealized +0.4%
DYAX CORP 1.4%
Value ($000) $12,204 Shares 1,619,697 Est. Cost $3.46 Unrealized
NEWLINK GENETICS CORP 1.3%
Value ($000) $11,005 Shares 500,000 Est. Cost $19.72 Unrealized
MIRATI THERAPEUTICS INC 1.3%
Value ($000) $10,922 Shares 656,767 Est. Cost $15.39 Unrealized
ROCKWELL MED INC 1.2%
Value ($000) $10,440 Shares 1,000,000 Est. Cost Unrealized
ACHILLION PHARMACEUTICALS IN 1.2%
Value ($000) $9,957 Shares 3,000,000 Est. Cost $4.78 Unrealized
BLUEBIRD BIO INC 1.1%
Value ($000) $9,806 Shares 467,418 Est. Cost $26.96 Unrealized
OCERA THERAPEUTICS INC 1.0%
Value ($000) $8,595 Shares 661,696 Est. Cost $11.51 Unrealized
ENZO BIOCHEM INC 0.8%
Value ($000) $6,624 Shares 2,268,653 Est. Cost $2.08 Unrealized
MGNX MACROGENICS INC 0.6%
Value ($000) $5,469 Shares 199,398 Est. Cost $26.16 Unrealized 0.0%
PSIVIDA CORP 0.5%
Value ($000) $4,715 Shares 1,187,608 Est. Cost $3.97 Unrealized
DYAX CORP 0.4%
Value ($000) $3,768 Shares 500,000 Est. Cost $3.46 Unrealized
MEI PHARMA INC 0.4%
Value ($000) $3,271 Shares 408,333 Est. Cost $8.01 Unrealized
CHELSEA THERAPEUTICS INTL LT 0.3%
Value ($000) $2,957 Shares 666,667 Est. Cost $4.44 Unrealized
CORONADO BIOSCIENCES INC 0.3%
Value ($000) $2,630 Shares 1,000,000 Est. Cost Unrealized